LENZ Therapeutics Inc. (LENZ)
25.30
-0.95 (-3.62%)
At close: Jan 29, 2025, 3:59 PM
25.18
-0.47%
After-hours Jan 29, 2025, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -124.65M | -101.05M | -70.76M | -68.37M | -109.00K |
| Depreciation & Amortization | 2.41M | 8.35M | 734.00K | 121.00K | n/a |
| Stock-Based Compensation | n/a | 721.00K | 196.00K | n/a | n/a |
| Other Working Capital | -36.87M | -7.40M | -4.32M | 1.11M | 22.00K |
| Other Non-Cash Items | 71.46M | 28.43M | 19.32M | 57.47M | 92.00K |
| Deferred Income Tax | n/a | -17.22M | 161.00K | n/a | n/a |
| Change in Working Capital | -39.22M | -7.21M | -2.50M | 1.71M | 10.00K |
| Operating Cash Flow | -90.01M | -87.98M | -52.85M | -8.72M | -19.00K |
| Capital Expenditures | -10.86M | -6.59M | -5.74M | -1.54M | n/a |
| Acquisitions | 1.90M | n/a | n/a | n/a | n/a |
| Purchase of Investments | -28.13M | -405.52M | n/a | n/a | n/a |
| Sales Maturities Of Investments | 263.43M | 170.25M | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a |
| Investing Cash Flow | 226.35M | -241.86M | -5.74M | -1.54M | n/a |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | -67.00K | -79.00K | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | n/a | 30.13M | 23.07M | n/a | n/a |
| Financial Cash Flow | 190.00K | 597.00K | 417.47M | 30.08M | n/a |
| Net Cash Flow | 138.13M | -329.25M | 357.16M | 19.81M | -19.00K |
| Free Cash Flow | -100.86M | -94.57M | -58.59M | -10.27M | -19.00K |